CytoSorbents has patented a connector assembly and method for modifying components in an extracorporeal circuit system. The invention allows for seamless replacement of components during operation, enhancing the efficiency and functionality of extracorporeal membrane oxygenation systems. GlobalData’s report on CytoSorbents gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on CytoSorbents, Wearable breast pumps was a key innovation area identified from patents. CytoSorbents's grant share as of May 2024 was 39%. Grant share is based on the ratio of number of grants to total number of patents.
Method of modifying ecmo system components during operation
A recently granted patent (Publication Number: US11969535B2) discloses a method for modifying a component in an extracorporeal membrane oxygenation (ECMO) system while the system is in operation. The method involves opening the active bypass to allow fluid to flow through both the active bypass and the active pathway from the inlet to the outlet. This process includes closing the active pathway to obstruct fluid flow through the lumen and disconnecting the component from the ECMO system by disengaging it from the connector's connection interface. The method also includes switching closure mechanisms and valves to control fluid flow and involves flushing the ECMO system with saline solution.
Furthermore, the patent claims detail additional steps such as operating the ECMO system continuously for up to 30 days, using blood plasma as the fluid, and incorporating a cartridge with a sorbent material in the system. The method also includes connecting a replacement component, such as a replacement cartridge with sorbent material, to the ECMO system and controlling fluid flow rates through the lumen. The patent also describes the presence of various closure mechanisms and ports within the ECMO system to facilitate flushing and maintenance procedures. Overall, the patented method provides a detailed process for modifying components within an ECMO system during operation, ensuring efficient and controlled fluid flow through the system.
To know more about GlobalData’s detailed insights on CytoSorbents, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.